Capstone Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Capstone Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-109,059	Closed	-$5.05M	–	1503
2019 Q2	$5.05M	Buy	+109,059	New	+$3.06M	0.04%	454

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Capstone Investment Advisors's ARRY Position: Q3 2019 in Review

Capstone Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 109,059 shares — an estimated $5.05M sold.

Capstone Investment Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $5.05M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Capstone Investment Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Capstone Investment Advisors sold 109,059 Array Biopharma Inc shares in Q3 2019, an estimated $5.05M.
Capstone Investment Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Capstone Investment Advisors's Array Biopharma Inc position peaked at $5.05M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Capstone Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.